Susquehanna International Group
RVMD icon

Susquehanna International Group’s Revolution Medicines RVMD Stock Holding History

Susquehanna International Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113M Buy
1,158,500
+271,400
+31% +$27.4M 0.01% 756
2025
Q4 		$70.7M Buy
887,100
+133,900
+18% +$8.78M 0.01% 1106
2025
Q3 		$35.2M Buy
753,200
+552,700
+276% +$21.6M ﹤0.01% 1643
2025
Q2 		$7.38M Buy
200,500
+99,000
+98% +$3.8M ﹤0.01% 3295
2025
Q1 		$3.59M Sell
101,500
-157,900
-61% -$6.41M ﹤0.01% 4300
2024
Q4 		$11.3M Buy
259,400
+117,600
+83% +$5.93M ﹤0.01% 2507
2024
Q3 		$6.43M Buy
141,800
+24,400
+21% +$1.06M ﹤0.01% 3193
2024
Q2 		$4.56M Buy
117,400
+23,400
+25% +$875K ﹤0.01% 3603
2024
Q1 		$3.03M Sell
94,000
-101,500
-52% -$3.01M ﹤0.01% 4496
2023
Q4 		$5.61M Buy
195,500
+20,800
+12% +$500K ﹤0.01% 3519
2023
Q3 		$4.84M Buy
174,700
+133,800
+327% +$3.97M ﹤0.01% 3592
2023
Q2 		$1.09M Sell
40,900
-4,600
-10% -$113K ﹤0.01% 6469
2023
Q1 		$986K Buy
+45,500
New +$1.12M ﹤0.01% 6850
2022
Q4 		– Sell
-14,700
Closed -$290K – 13507
2022
Q3 		$290K Buy
+14,700
New +$323K ﹤0.01% 9880
2022
Q2 		– Sell
-12,400
Closed -$316K – 13804
2022
Q1 		$316K Sell
12,400
-6,700
-35% -$146K ﹤0.01% 10146
2021
Q4 		$481K Buy
19,100
+10,400
+120% +$293K ﹤0.01% 9317
2021
Q3 		$239K Sell
8,700
-22,300
-72% -$649K ﹤0.01% 11106
2021
Q2 		$984K Sell
31,000
-400
-1% -$14K ﹤0.01% 7809
2021
Q1 		$1.44M Buy
+31,400
New +$1.41M ﹤0.01% 6757

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Susquehanna International Group's RVMD Position: Q1 2026 in Review

Susquehanna International Group reduced its Revolution Medicines (RVMD) stake by 72% in Q1 2026, selling an estimated $13.3M and leaving 51,385 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #4223.

Susquehanna International Group first reported a position in RVMD in Q1 2020 and has held it in 24 quarters since. The position peaked at $14.6M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Susquehanna International Group held 51,385 shares of Revolution Medicines worth $5M as of Q1 2026.
  • Susquehanna International Group sold 131,836 Revolution Medicines shares in Q1 2026, an estimated $13.3M.
  • Revolution Medicines made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4223 holding.
  • Susquehanna International Group first reported a position in Revolution Medicines in Q1 2020 and has held it in 24 quarters since.
  • Susquehanna International Group's Revolution Medicines position peaked at $14.6M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.